v1
A phase II study to determine the efficacy and tolerability of intravenous ZD9331 in heavily pretreated patients with ovarian cancer.
Identifier:nobleid.org/w1/20260515/CB7FD101
Type:Journal Article
0 views
Embeddable Badge
[](https://nobleid.org/work/w1/20260515/CB7FD101)
Bibliometric Analysis
Impact metrics, research fronts, co-authorship networks →
Authors & Claims